← Open Payments lookup

LUIS VINUELA: Open Payments

NPI 1710943311 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,067 in 52 payments from 13 companies in 2025. Trend: 2023 $1,503 · 2024 $1,213 · 2025 $1,067

Food & beverage: $1,067
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$292
Alkermes, Inc.10$151
E.R. Squibb & Sons, L.L.C.5$111
Vanda Pharmaceuticals Inc.5$100
ABBVIE INC.4$91
Takeda Pharmaceuticals U.S.A., Inc.3$72
Teva Pharmaceuticals USA, Inc.4$68
Lundbeck LLC2$45
Neurocrine BioSciences, Inc.2$44
Janssen Pharmaceuticals, Inc2$33

Products named: CAPLYTA, ARISTADA, COBENFY, FANAPT, VRAYLAR, TRINTELLIX, UZEDY, REXULTI.

Industry payments across FL — which companies pay providers there.